Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias
Launched by NORTHWELL HEALTH · Feb 4, 2019
Trial Information
Current as of May 05, 2025
Completed
Keywords
ClinConnect Summary
Until recently, the only non-invasive diagnostic modality to help identify the location of ventricular arrhythmias was the 12 lead ECG. The Medtronic CardioInsight wearable vest is a recently FDA approved diagnostic modality noninvasive, single beat cardiac mapping system that provides 3D electroanatomic maps of the ventricular chambers. CardioInsight projects unipolar signals collected from a 252-electrode vest to cardiac chambers imaged with a non-contrast CT of the chest. The created non-invasive 3D electroanatomical maps can be evaluated by the physicians pre-procedurally but also durin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patients with PVCs or VT requiring EPS for:
- • Symptomatic arrhythmias
- • High PVC burden
- • Presence of cardiomyopathy
- • Risk stratification to determine which patients to offer ablative vs medical therapy and for ICD implantation if deemed high risk for sudden cardiac death.
- Exclusion Criteria:
- • Patients in acute coronary syndrome
- • Patient with congestive heart failure in acute decompensation
- • Patients in rapid atrial fibrillation
- • Patients requiring persistent ventricular pacing
- • Patient who refuse to undergo EPS
About Northwell Health
Northwell Health is a leading integrated health system based in New York, dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to improving patient outcomes and enhancing medical knowledge, Northwell Health conducts a diverse range of clinical studies across various therapeutic areas. The organization harnesses its extensive network of hospitals, outpatient facilities, and research institutes to facilitate cutting-edge research, ensuring access to advanced treatments for patients while fostering collaboration among healthcare professionals, researchers, and industry partners. By prioritizing patient-centric approaches and leveraging state-of-the-art technology, Northwell Health aims to drive significant advancements in medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Stavros Mountantonakis, MD
Principal Investigator
Northwell Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials